Breakthroughs in Melanoma – Insights from ESMO 2024.
White Paper based on late-breaking abstracts presented in Barcelona.
The advancements in melanoma therapies presented at this year’s ESMO conference mark a transformative shift in the treatment landscape, with Real-World Evidence (RWE) playing a pivotal role in personalizing patient care. By integrating real-world data with clinical trial results, we are moving toward more targeted and effective treatment options for melanoma patients.
“Breakthroughs in Melanoma” is the first in OXON’s white paper series, derived from insights gained at ESMO 2024. This series provides a summary of key findings from completed and ongoing trials that may shape future oncology guidelines, while also examining the critical role RWE can play in bridging current evidence gaps. “Breakthroughs in Melanoma” synthesizes these insights with established oncology RWE guidelines and protocols, providing a comprehensive overview of the developments that are shaping the future of melanoma care.
To download the white paper, please complete the following form.